Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Controlling demand

Controlling demand

The national debate on health care has taken as a given the premise that the United States is spending an excessive proportion of its gross domestic product on health care.

So when Stephen Lurito, who manages Warburg Pincus Counsellors' Emerging Growth Fund questioned that assumption in

Read the full 475 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers